Method of treating acromegaly, hyperprolactinemia, portal hypertension and gastrointestinal bleeding with somatostatin-dopamine chimeric analogs

Details for Australian Patent Application No. 2008200694 (hide)

Owner IPSEN Pharma S.A.S.

Inventors Shen, Yeelana; Dong, Zheng Xin; Culler, Michael Dewitt

Agent Griffith Hack

Pub. Number AU-B-2008200694

Parent 2004229437

Filing date 14 February 2008

Wipo publication date 6 March 2008

Acceptance publication date 14 April 2011

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

Event Publications

6 March 2008 Application Open to Public Inspection

  Published as AU-B-2008200694

6 March 2008 Complete Application Filed

12 March 2009 Alteration of Name

  The name of the applicant has been altered to IPSEN Pharma S.A.S

14 April 2011 Application Accepted

  Published as AU-B-2008200694

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200695-Joining apparatus with rotatable magnet therein having separation preventing means including a magnet installation member and built-up type toy with the same

2008200693-Treatment of disease or condition with somatostatin-dopamine chimeric analogs